HomeCompareKIN vs STAG

KIN vs STAG: Dividend Comparison 2026

KIN yields 21.62% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KIN wins by $62.3K in total portfolio value
10 years
KIN
KIN
● Live price
21.62%
Share price
$9.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.6K
Annual income
$7,983.46
Full KIN calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — KIN vs STAG

📍 KIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKINSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KIN + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KIN pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIN
Annual income on $10K today (after 15% tax)
$1,837.84/yr
After 10yr DRIP, annual income (after tax)
$6,785.94/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, KIN beats the other by $6,393.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIN + STAG for your $10,000?

KIN: 50%STAG: 50%
100% STAG50/50100% KIN
Portfolio after 10yr
$49.5K
Annual income
$4,222.84/yr
Blended yield
8.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

KIN
No analyst data
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIN buys
0
STAG buys
0
No recent congressional trades found for KIN or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKINSTAG
Forward yield21.62%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$80.6K$18.3K
Annual income after 10y$7,983.46$462.22
Total dividends collected$47.7K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: KIN vs STAG ($10,000, DRIP)

YearKIN PortfolioKIN Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$12,862$2,162.16$10,665$345.09+$2.2KKIN
2$16,362$2,599.07$11,364$357.70+$5.0KKIN
3$20,597$3,089.91$12,098$370.43+$8.5KKIN
4$25,674$3,635.27$12,869$383.28+$12.8KKIN
5$31,706$4,234.91$13,677$396.23+$18.0KKIN
6$38,813$4,887.76$14,524$409.27+$24.3KKIN
7$47,122$5,591.96$15,411$422.41+$31.7KKIN
8$56,765$6,344.91$16,339$435.61+$40.4KKIN
9$67,882$7,143.35$17,311$448.89+$50.6KKIN
10$80,618$7,983.46$18,327$462.22+$62.3KKIN

KIN vs STAG: Complete Analysis 2026

KINStock

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

Full KIN Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this KIN vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIN vs SCHDKIN vs JEPIKIN vs OKIN vs KOKIN vs MAINKIN vs PLDKIN vs EQRKIN vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.